Advisory Board

De Mello has established an international group of highly experienced professionals from the life science, biotech, pharmaceutical industry, scientific community and venture capital sector. These 'partners' have long-standing track-records in their respective fields and industries and bring complementary skill-sets to De Mello.

The members of the Advisory Board assist De Mello's management in their in-depth scientific, business and industrial due diligence of investment opportunities and companies. The information about the latest developments in life science, biotechnology and healthcare industry is essential for the daily management of De Mello.

Dr. François Guinot
Prof. dr. Max Fehlman
Prof. dr. Herjan Coelingh Bennink
Ir. Rob de Visser
Dr. Edzerd Brons
Dr. John Burke
Dr. Zsolt Lavotha
Dr. Robert Rubenstein